Dr. Reddy’s Laboratories Ltd ADR

Stock Chart, Company Information, and Scan Results

$13.36(as of Jun 11, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Dr. Reddy’s Laboratories Ltd ADR Company Information, Fundamentals, and Technical Indicators

Stock Price$13.36
Ticker SymbolRDY
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees27,527
CountyUSA
Market Cap$11,133.2M
EBIDTA68,149.0M
10-Day Moving Average13.27
P/E Ratio0.26
20-Day Moving Average13.42
Forward P/E Ratio24.88
50-Day Moving Average13.34
Earnings per Share0.54
200-Day Moving Average13.87
Profit Margin2.93%
RSI49.80
Shares Outstanding832.7M
ATR0.27
52-Week High15.87
Volume1,043,395
52-Week Low12.19
Most Recent Support Level13.19
Book Value372,925.0M
Most Recent Resistance Level13.47
P/B Ratio0.03
Upper Keltner14.02
P/S Ratio0.03
Lower Keltner12.82
Debt-to-Equity Ratio14.02
Next Earnings Date07/21/2026
Cash Surplus-149,184.9M
Next Ex-Dividend Date07/09/2026

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Dr. Reddy’s Laboratories Ltd ADR In Our Stock Scanner

As of Jun 12, 2026
example chart graphic
Scan Name: Low PE RatiosScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Blue Chip Stocks with Low PE RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Dragonfly DojiScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.